202 related articles for article (PubMed ID: 31038055)
21. Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.
Zhang C; Liu J; Zhao Y; Yue X; Zhu Y; Wang X; Wu H; Blanco F; Li S; Bhanot G; Haffty BG; Hu W; Feng Z
Elife; 2016 Jan; 5():e10727. PubMed ID: 26751560
[TBL] [Abstract][Full Text] [Related]
22. The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers.
Basheer HA; Elsalem L; Salem A; Tailor A; Hunter K; Afarinkia K
Curr Cancer Drug Targets; 2022; 22(2):169-179. PubMed ID: 34951574
[TBL] [Abstract][Full Text] [Related]
23. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
24. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
Hoerner CR; Chen VJ; Fan AC
Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
[TBL] [Abstract][Full Text] [Related]
25. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases.
Szeliga M; Obara-Michlewska M
Neurochem Int; 2009; 55(1-3):71-5. PubMed ID: 19428809
[TBL] [Abstract][Full Text] [Related]
26. The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer.
Masisi BK; El Ansari R; Alfarsi L; Craze ML; Jewa N; Oldfield A; Cheung H; Toss M; Rakha EA; Green AR
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439127
[TBL] [Abstract][Full Text] [Related]
27. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
[TBL] [Abstract][Full Text] [Related]
28. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies.
Wang Z; Liu F; Fan N; Zhou C; Li D; Macvicar T; Dong Q; Bruns CJ; Zhao Y
Front Oncol; 2020; 10():589508. PubMed ID: 33194749
[TBL] [Abstract][Full Text] [Related]
29. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
30. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
Masamha CP; LaFontaine P
J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
[TBL] [Abstract][Full Text] [Related]
31. [
Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.
Li HJ; Li X; Pang H; Pan JJ; Xie XJ; Chen W
Jpn J Clin Oncol; 2015 Nov; 45(11):1055-63. PubMed ID: 26373319
[TBL] [Abstract][Full Text] [Related]
33. The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.
Pasquali CC; Islam Z; Adamoski D; Ferreira IM; Righeto RD; Bettini J; Portugal RV; Yue WW; Gonzalez A; Dias SMG; Ambrosio ALB
J Biol Chem; 2017 Jul; 292(27):11572-11585. PubMed ID: 28526749
[TBL] [Abstract][Full Text] [Related]
34. Glutaminase Affects the Transcriptional Activity of Peroxisome Proliferator-Activated Receptor γ (PPARγ) via Direct Interaction.
de Guzzi Cassago CA; Dias MM; Pinheiro MP; Pasquali CC; Bastos ACS; Islam Z; Consonni SR; de Oliveira JF; Gomes EM; Ascenção CFR; Honorato R; Pauletti BA; Indolfo NC; Filho HVR; de Oliveira PSL; Figueira ACM; Paes Leme AF; Ambrosio ALB; Dias SMG
Biochemistry; 2018 Nov; 57(44):6293-6307. PubMed ID: 30295466
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activation.
Meng G; Xia M; Xu C; Yuan D; Schnurr M; Wei J
Int J Cancer; 2014 Apr; 134(8):1958-71. PubMed ID: 23921958
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis.
Han T; Zhan W; Gan M; Liu F; Yu B; Chin YE; Wang JB
Cell Res; 2018 Jun; 28(6):655-669. PubMed ID: 29515166
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting Glutamine Metabolism Blocks Coronavirus Replication in Mammalian Cells.
Greene KS; Choi A; Chen M; Yang N; Li R; Qiu Y; Lukey MJ; Rojas KS; Shen J; Wilson KF; Katt WP; Whittaker GR; Cerione RA
bioRxiv; 2023 Sep; ():. PubMed ID: 37808692
[TBL] [Abstract][Full Text] [Related]
38. c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity.
Wang T; Cai B; Ding M; Su Z; Liu Y; Shen L
Am J Med Sci; 2019 Sep; 358(3):235-242. PubMed ID: 31324362
[TBL] [Abstract][Full Text] [Related]
39. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.
Yu D; Shi X; Meng G; Chen J; Yan C; Jiang Y; Wei J; Ding Y
Oncotarget; 2015 Apr; 6(10):7619-31. PubMed ID: 25844758
[TBL] [Abstract][Full Text] [Related]
40. Regulation of glutaminase activity and glutamine metabolism.
Curthoys NP; Watford M
Annu Rev Nutr; 1995; 15():133-59. PubMed ID: 8527215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
